Detalhe da pesquisa
1.
Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer.
Proc Natl Acad Sci U S A
; 118(21)2021 05 25.
Artigo
Inglês
| MEDLINE | ID: mdl-34021083
2.
Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer.
Clin Cancer Res
; 27(7): 2023-2037, 2021 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33495315
3.
SOAT1 promotes mevalonate pathway dependency in pancreatic cancer.
J Exp Med
; 217(9)2020 09 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32633781
4.
IL1-Induced JAK/STAT Signaling Is Antagonized by TGFß to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma.
Cancer Discov
; 9(2): 282-301, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30366930
5.
Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer.
Clin Cancer Res
; 25(22): 6742-6755, 2019 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31492749
6.
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice.
Science
; 364(6446): 1156-1162, 2019 06 21.
Artigo
Inglês
| MEDLINE | ID: mdl-31221853
7.
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.
J Exp Med
; 214(3): 579-596, 2017 03 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28232471